Inspire Investing, LLC Biocryst Pharmaceuticals Inc Transaction History

Inspire Investing, LLC

$858 Million
Q4 2024

A detailed history of Inspire Investing, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Inspire Investing, LLC holds 53,479 shares of BCRX stock, worth $538,533. This represents 0.05% of its overall portfolio holdings.

Number of Shares

53,479

Previous 158,008 66.15%

Holding current value

$538,533

Previous $1.2 Million 66.5%

% of portfolio

0.05%

Previous 0.13%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	SELL	$7.03 - $8.43 $734,838 - $881,179	-104,529 Reduced 66.15%	53,479 $402,000
Q3 2024 Oct 10, 2024	BUY	$6.41 - $8.69 $643,935 - $872,980	100,458 Added 174.56%	158,008 $1.2 Million
Q2 2024 Aug 12, 2024	SELL	$4.13 - $6.79 $49,213 - $80,909	-11,916 Reduced 17.15%	57,550 $355,000
Q1 2024 May 07, 2024	BUY	$4.89 - $7.65 $30,029 - $46,978	6,141 Added 9.7%	69,466 $352,000
Q4 2023 Feb 12, 2024	BUY	$4.98 - $6.77 $100,869 - $137,126	20,255 Added 47.03%	63,325 $379,000
Q3 2023 Oct 26, 2023	SELL	$6.71 - $7.92 $10,152 - $11,982	-1,513 Reduced 3.39%	43,070 $304,000
Q2 2023 Jul 31, 2023	BUY	$6.96 - $8.81 $85,148 - $107,781	12,234 Added 37.82%	44,583 $313,000
Q1 2023 Apr 24, 2023	BUY	$7.94 - $11.84 $91,778 - $136,858	11,559 Added 55.6%	32,349 $269,000
Q4 2022 Jan 26, 2023	BUY	$10.5 - $14.2 $46,221 - $62,508	4,402 Added 26.86%	20,790 $0
Q3 2022 Nov 07, 2022	BUY	$10.79 - $14.81 $176,826 - $242,706	16,388 New	16,388 $206,000

Others Institutions Holding BCRX

# of Institutions

292

Shares Held

177M

Call Options Held

721K

Put Options Held

489K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.87B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account

Inspire Investing, LLC Biocryst Pharmaceuticals Inc Transaction History